Cheng-Yu Chen

Title: Cheng-Yu Chen: Innovator in Cancer Treatment

Introduction

Cheng-Yu Chen is an inventor based in Taichung, Taiwan. He has made significant contributions to the field of cancer treatment, particularly in the development of innovative drug delivery systems. Although he currently holds no granted patents, his research and patent applications reflect his dedication to advancing medical science.

Latest Patent Applications

Cheng-Yu Chen's latest patent applications include:

1. **Exosomes for treating glioblastoma multiforme and manufacturing method thereof** - This application describes a drug carrier that can cross the blood-brain barrier. It comprises an extracellular vesicle with a human leukocyte antigen-G antibody on its surface. This carrier is designed to promote apoptosis of brain tumor cells, inhibit their growth, and reduce the expression of O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells. These effects are crucial for the treatment of glioblastoma multiforme (GBM).

2. **Production of exosomes and uses thereof** - This application outlines a method for producing exosomes on a large scale using a cyclic tensile bioreactor to stimulate cells to release exosomes. Additionally, the exosome, which has an anti-HLA-G protein specific for cancer, is utilized as a delivery vehicle for therapeutic agents aimed at treating cancer.

Conclusion

Cheng-Yu Chen's innovative work in the field of cancer treatment showcases his commitment to improving patient outcomes through advanced drug delivery systems. His research has the potential to significantly impact the treatment of glioblastoma multiforme and other cancers.